医学
宫颈癌
彭布罗利珠单抗
放化疗
放射治疗
肿瘤科
阶段（地层学）
养生
内科学
核医学
癌症
免疫疗法
古生物学
生物
作者
Domenica Lorusso,Yang Xiang,K. Hasegawa,Giovanni Scambia,M.H. Leiva Galves,Pierre Elias,Andrés Acevedo,Júlia Vízkeleti,A.J.P.D.S. Gomes,Fernando Contreras Mejía,Allison B. Reiss,Asude Ayhan,J-Y Lee,В. В. Саевец,Flora Zagouri,K. Li,K.U. Yamada,Sarper Toker,Sandro Pignata,Linda Duska
标识
DOI：10.1016/j.annonc.2023.10.032
摘要
Pembrolizumab (pembro) has shown efficacy in patients (pts) with cervical cancer. The effect of chemoradiotherapy may be enhanced by immunotherapy. ENGOT-cx11/GOG-3047/KEYNOTE-A18(NCT04221945) assessed the efficacy and safety of pembro + concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI
凤凰
InfoNinja
嗯哼
丰知然
坚强的广山
Andrew
张三坟
干净的铅笔
热心市民小红花
薰硝壤
三黑猫
于芋菊
非洲大象
Yziii
犹豫小海豚
Singularity
psyduck
rosalieshi
梦之凌云
tuanheqi
皖公网安备34019202002308
